Northwestern Mutual Wealth Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.23K | Sell |
1,880
-1,000
| -35% | -$1.72K | ﹤0.01% | 3131 |
|
|
2025
Q1 | $9.59K | Buy |
2,880
+906
| +46% | +$3.02K | ﹤0.01% | 2765 |
|
|
2024
Q4 | $14.6K | Sell |
1,974
-215
| -10% | -$1.59K | ﹤0.01% | 2615 |
|
|
2024
Q3 | $20.6K | Buy |
2,189
+309
| +16% | +$2.9K | ﹤0.01% | 2458 |
|
|
2024
Q2 | $15.1K | Hold |
1,880
| – | – | ﹤0.01% | 2500 |
|
|
2024
Q1 | $27.9K | Hold |
1,880
| – | – | ﹤0.01% | 2300 |
|
|
2023
Q4 | $15.3K | Hold |
1,880
| – | – | ﹤0.01% | 2491 |
|
|
2023
Q3 | $8.55K | Hold |
1,880
| – | – | ﹤0.01% | 2592 |
|
|
2023
Q2 | $13.2K | Hold |
1,880
| – | – | ﹤0.01% | 2462 |
|
|
2023
Q1 | $11.5K | Hold |
1,880
| – | – | ﹤0.01% | 2466 |
|
|
2022
Q4 | $12K | Hold |
1,880
| – | – | ﹤0.01% | 2427 |
|
|
2022
Q3 | $18K | Hold |
1,880
| – | – | ﹤0.01% | 2261 |
|
|
2022
Q2 | $21K | Buy |
1,880
+1,300
| +224% | +$14.5K | ﹤0.01% | 2232 |
|
|
2022
Q1 | $10K | Hold |
580
| – | – | ﹤0.01% | 2536 |
|
|
2021
Q4 | $11K | Sell |
580
-17
| -3% | -$322 | ﹤0.01% | 2544 |
|
|
2021
Q3 | $14K | Buy |
597
+17
| +3% | +$399 | ﹤0.01% | 2351 |
|
|
2021
Q2 | $15K | Hold |
580
| – | – | ﹤0.01% | 2301 |
|
|
2021
Q1 | $18K | Buy |
+580
| New | +$18K | ﹤0.01% | 2091 |
|